126 related articles for article (PubMed ID: 38403176)
1. The presence of exudative thickening of Bowman's capsule predict poor prognosis in diabetic kidney disease.
Lu J; Xie K; Che X; Song A; Zhang M; Qi C; Lu R; Fan Y; Liu N; Huang Z; Peng Y; Fan Q; Wang N; Yao L; Gu L
Diabetes Res Clin Pract; 2024 Mar; 209():111594. PubMed ID: 38403176
[TBL] [Abstract][Full Text] [Related]
2. Glomerular parietal epithelial cell activation induces collagen secretion and thickening of Bowman's capsule in diabetes.
Holderied A; Romoli S; Eberhard J; Konrad LA; Devarapu SK; Marschner JA; Müller S; Anders HJ
Lab Invest; 2015 Mar; 95(3):273-82. PubMed ID: 25531564
[TBL] [Abstract][Full Text] [Related]
3. Association of Bowman's capsule rupture with prognosis in patients with lupus nephritis.
Duan T; Zhu X; Zhao Q; Xiao L; He L; Liu H; Chen A; Duan S; Yuan S; Tang C; Yuan F; Zhu J; Zhu X; Cheng M; Liu Y; Liu Y; Liu F; Sun L
J Nephrol; 2022 May; 35(4):1193-1204. PubMed ID: 35435603
[TBL] [Abstract][Full Text] [Related]
4. Gas1 expression in parietal cells of Bowman's capsule in experimental diabetic nephropathy.
Luna-Antonio BI; Rodriguez-Muñoz R; Namorado-Tonix C; Vergara P; Segovia J; Reyes JL
Histochem Cell Biol; 2017 Jul; 148(1):33-47. PubMed ID: 28315934
[TBL] [Abstract][Full Text] [Related]
5. De novo expression of sodium-glucose cotransporter SGLT2 in Bowman's capsule coincides with replacement of parietal epithelial cell layer with proximal tubule-like epithelium.
Tabatabai NM; North PE; Regner KR; Kumar SN; Duris CB; Blodgett AB
J Membr Biol; 2014 Aug; 247(8):675-83. PubMed ID: 24906870
[TBL] [Abstract][Full Text] [Related]
6. Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy.
Mader JR; Resch ZT; McLean GR; Mikkelsen JH; Oxvig C; Marler RJ; Conover CA
J Endocrinol; 2013 Oct; 219(1):51-8. PubMed ID: 23881937
[TBL] [Abstract][Full Text] [Related]
7. Neutrophils associate with Bowman's capsule rupture specifically in PR3-ANCA glomerulonephritis.
Hakroush S; Tampe B
J Nephrol; 2022 May; 35(4):1177-1183. PubMed ID: 34851509
[TBL] [Abstract][Full Text] [Related]
8. Parietal podocytes in normal human glomeruli.
Bariety J; Mandet C; Hill GS; Bruneval P
J Am Soc Nephrol; 2006 Oct; 17(10):2770-80. PubMed ID: 16943305
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Pathobiology of Diabetic Kidney Disease.
Thomas MC
Adv Chronic Kidney Dis; 2021 Jul; 28(4):282-289. PubMed ID: 34922684
[TBL] [Abstract][Full Text] [Related]
10. Metaplasia of the parietal layer of Bowman's capsule in the human kidney: incidence in alcoholic liver disease and hypertension.
Haensly WE
Histol Histopathol; 1988 Jul; 3(3):235-40. PubMed ID: 2980229
[TBL] [Abstract][Full Text] [Related]
11. Metaplasia of the parietal layer of Bowman's capsule: a histopathological survey of the human kidney.
Haensly WE; Lee JC
Histol Histopathol; 1986 Oct; 1(4):363-7. PubMed ID: 2980131
[TBL] [Abstract][Full Text] [Related]
12. Bowman's capsule rupture and the Oxford MEST-C score in adult patients with Immunoglobulin a vasculitis nephritis: a single center experience.
Zhao Q; Duan T; Chen A; He L; Liu H; Yuan S; Tang C; Liu Y; Liu Y; Liu F; Xiao L; Zhu X; Sun L
Ann Med; 2023 Dec; 55(1):2215538. PubMed ID: 37246836
[TBL] [Abstract][Full Text] [Related]
13. Bowman's capsule provides a protective niche for podocytes from cytotoxic CD8+ T cells.
Chen A; Lee K; D'Agati VD; Wei C; Fu J; Guan TJ; He JC; Schlondorff D; Agudo J
J Clin Invest; 2018 Aug; 128(8):3413-3424. PubMed ID: 29985168
[TBL] [Abstract][Full Text] [Related]
14. Adenomatous Hyperplasia of Bowman's Capsule Epithelium in a Dog with Metastatic Nasal and Hepatic Neuroendocrine Carcinoma.
Machida Y; Higo M; Doge S; Nagashima T; Kishimoto TE; Yoshimura H; Yamamoto M; Okada K; Yayoshi N; Hatakeyama H; Michishita M
J Comp Pathol; 2022 Sep; 197():19-22. PubMed ID: 36089292
[TBL] [Abstract][Full Text] [Related]
15. Immune complex deposition in Bowman's capsule is associated with parietal podocytes.
Gibson IW; Downie TT; More IA; Lindop GB
J Pathol; 1994 May; 173(1):53-9. PubMed ID: 7931837
[TBL] [Abstract][Full Text] [Related]
16. Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.
Chen S; Chen L; Jiang H
Ren Fail; 2022 Dec; 44(1):1309-1318. PubMed ID: 35938702
[TBL] [Abstract][Full Text] [Related]
17. Low hemoglobin levels are associated with Bowman's capsule rupture and peritubular capillaritis in ANCA-associated renal vasculitis: a link of vascular injury to anemia?
Baier E; Kluge IA; Hakroush S; Tampe B
J Nephrol; 2023 Nov; 36(8):2305-2316. PubMed ID: 37676636
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between Serum 25-Hydroxyvitamin D Levels in Albuminuria Progression of Diabetic Kidney Disease and Underlying Mechanisms By Bioinformatics Analysis.
Huang B; Wen W; Ye S
Front Endocrinol (Lausanne); 2022; 13():880930. PubMed ID: 35634488
[TBL] [Abstract][Full Text] [Related]
19. Assessment of detached podocytes in the Bowman's space as a marker of disease activity in lupus nephritis.
Moustafa FE; Soliman NA; Bakr AM; El Shwaf IM
Lupus; 2014 Feb; 23(2):146-50. PubMed ID: 24306541
[TBL] [Abstract][Full Text] [Related]
20. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
